The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
HSPB3 (UniProt accession Q12988) encodes heat shock protein beta-3 (HspB3), also known as HSP17 or HSPL27, a member of the small heat shock protein (sHSP/HSPB) family in humans (tedesco2022insightsonhuman pages 1-2, boelens2020structuralaspectsof pages 1-2). This ~17 kDa protein (150 amino acids) belongs to the HSP20 family and is characterized by a conserved α-crystallin domain (ACD) flanked by variable N- and C-terminal regions (tedesco2022insightsonhuman pages 1-2, tiago2021smallheatshockprotein pages 2-4). HSPB3 represents one of ten human small heat shock proteins (HSPB1-10) and is distinguished by its tissue-restricted expression pattern and specialized function in neuromuscular tissues (gu2023functionaldiversityof pages 1-3, boelens2020structuralaspectsof pages 1-2).
HSPB3 possesses the canonical α-crystallin domain that defines the sHSP family, but displays unique structural features that distinguish it from other family members (tedesco2022insightsonhuman pages 1-2, tiago2021smallheatshockprotein pages 2-4). Unlike several other HSPBs, HSPB3 lacks the typical C-terminal architecture associated with robust oligomerization and possesses a unique N-terminal domain (tiago2021smallheatshockprotein pages 2-4, tedesco2022insightsonhuman pages 2-5). The protein contains an I/V-X-I/V motif in its N-terminal region rather than the C-terminus, which contributes to its distinctive assembly properties (tedesco2022insightsonhuman pages 1-2, clark2018terminalregionsconfer pages 1-6).
A defining feature of HSPB3 is its obligate hetero-oligomerization with HSPB2. HSPB3 forms characteristic heterotetrameric complexes with HSPB2 in a specific 3:1 stoichiometric ratio (three HSPB2 molecules to one HSPB3 molecule), with higher-order assemblies (8-, 12-, 16-, and 24-mers) maintaining this fixed ratio (morelli2017aninteractionstudy pages 1-2, clark2018terminalregionsconfer pages 1-6). The crystal structure of the HSPB2/HSPB3 heterotetramer reveals that the four α-crystallin domains assemble into a flattened tetrahedral structure, with assembly mediated by flexible "nuts and bolts" interactions involving IXI/V motifs from terminal regions filling ACD pockets (clark2018terminalregionsconfer pages 1-6). This structural plasticity is thought to be important for the cytoprotective functions of these chaperones (clark2018terminalregionsconfer pages 1-6).
HSPB3 functions as an ATP-independent molecular chaperone (holdase), consistent with the canonical mechanism of small heat shock proteins (tedesco2022insightsonhuman pages 1-2, tiago2021smallheatshockprotein pages 2-4, tedesco2022insightsonhuman pages 2-5). Like other sHSPs, HSPB3 binds unfolding substrate proteins to prevent their aggregation and maintain them in a folding-competent state, subsequently cooperating with ATP-dependent chaperones such as HSP70/HSP40 for substrate refolding or routing to degradative pathways (tedesco2022insightsonhuman pages 1-2, boelens2020structuralaspectsof pages 1-2, tedesco2022insightsonhuman pages 2-5).
However, HSPB3 exhibits moderate or selective chaperone activity compared to the more promiscuous HSPB1, HSPB4, and HSPB5 proteins (tiago2021smallheatshockprotein pages 2-4, boelens2020structuralaspectsof pages 1-2). This relatively limited in vitro chaperone activity is attributed to HSPB3's unique structural features, particularly the absence of the typical C-terminal domain and its specialized N-terminal architecture (tiago2021smallheatshockprotein pages 2-4, boelens2020structuralaspectsof pages 1-2).
The most well-characterized substrate of HSPB3 is the lamin B receptor (LBR), an inner nuclear membrane protein that plays critical roles in chromatin organization and nuclear envelope structure (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6). This substrate relationship represents a remarkable specialization among sHSPs, which typically exhibit broad substrate promiscuity.
HSPB3 binds to LBR in the nucleoplasm and maintains it in a dynamic state, thereby regulating LBR localization and function (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6). Specifically, HSPB3 prevents LBR from becoming immobilized at the nuclear envelope and promotes its proper redistribution during cellular differentiation (tiago2021smallheatshockprotein pages 4-6). This chaperone-client relationship has been demonstrated through multiple experimental approaches, including co-immunoprecipitation, fluorescence recovery after photobleaching (FRAP) analyses showing that HSPB3 maintains LBR mobility in the nucleoplasm, and localization studies (tiago2021smallheatshockprotein pages 4-6).
HSPB3's regulation of LBR is functionally critical for muscle cell differentiation. During myoblast differentiation, chromatin must be reorganized through a process involving replacement of the LBR-chromatin tether with the lamin A/C (LMNA)-chromatin tether (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6). This "tether switch" is essential for remodeling discrete peripheral chromatin regions and inducing genes required for differentiation, including myogenic transcription factors and extracellular matrix components (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6).
HSPB3 facilitates this process by maintaining LBR in a dynamic nucleoplasmic state rather than allowing it to remain stably anchored at the nuclear envelope (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6). When HSPB3 is depleted, LBR becomes abnormally enriched and stabilized at the nuclear envelope, chromocenter reorganization is impaired, and expression of myogenic genes such as MYOG (myogenin) is reduced (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6). Conversely, HSPB3 overexpression is sufficient to induce differentiation in both normal myoblasts and rhabdomyosarcoma cells, which are malignant cells that fail to fully differentiate (tiago2021smallheatshockprotein pages 1-2).
HSPB3 exhibits a unique subcellular localization pattern among sHSPs, with prominent nuclear and nuclear envelope localization in addition to cytoplasmic distribution (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6). In differentiating myoblasts, HSPB3 shows heterogeneous distribution: some cells display cytoplasmic and nucleoplasmic localization, while others show enrichment at the nuclear envelope where it colocalizes with lamin B1 and forms nuclear filaments reminiscent of the lamin meshwork (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 4-6).
The nuclear localization of HSPB3 depends on its N-terminal domain, which promotes nuclear accumulation and contributes to its ability to form condensates (tiago2021smallheatshockprotein pages 4-6). Once inside the nucleus, the α-crystallin domain is sufficient to maintain the interaction with LBR and keep it in the nucleoplasm (tiago2021smallheatshockprotein pages 4-6). This nuclear/nuclear envelope localization distinguishes HSPB3 from many other sHSPs that are predominantly cytoplasmic (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 4-6).
Unlike most human sHSPs (including HSPB1, HSPB4, HSPB5, HSPB6, and HSPB8), which are imported into the mitochondrial intermembrane space under basal conditions and enriched after stress, HSPB3 is not imported into mitochondria (adriaenssens2023smallheatshock pages 1-2). This exclusion from mitochondria is likely related to HSPB3's obligate hetero-oligomerization with HSPB2, which may prevent mitochondrial import (adriaenssens2023smallheatshock pages 1-2). This finding further emphasizes HSPB3's specialized role in nuclear rather than mitochondrial proteostasis.
HSPB3 expression is highly restricted to specific tissues, contrasting with the ubiquitous expression of HSPB1, HSPB5, and HSPB8 (gu2023functionaldiversityof pages 1-3, tiago2021smallheatshockprotein pages 2-4, morelli2017aninteractionstudy pages 1-2). HSPB3 shows highest expression in skeletal muscle, with additional expression in cardiac muscle, differentiating myoblasts, motoneurons, and fetal brain (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 1-2, morelli2017aninteractionstudy pages 1-2). Notably, HSPB3 is absent from cycling myoblasts and is specifically induced during differentiation (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 1-2).
A unique feature of HSPB3 among sHSPs is its developmental regulation rather than classical stress induction. Unlike HSPB1 and HSPB5, which are induced by heat shock and other stressors, HSPB3 does not respond strongly to heat shock (tiago2021smallheatshockprotein pages 2-4, tedesco2022theroleof pages 1-2). Instead, HSPB3 is transcriptionally regulated by the myogenic transcription factor MYOD during muscle differentiation (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 1-2). ChIP-seq data demonstrate that MYOD binds to regulatory regions of the HSPB3 gene, with enhanced recruitment and increased H3K27 acetylation (an activating chromatin mark) observed in differentiated myotubes compared to proliferating myoblasts (tiago2021smallheatshockprotein pages 1-2).
This developmental regulation positions HSPB3 as part of the muscle-specific transcriptional program rather than the general cellular stress response (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 1-2, tedesco2022theroleof pages 1-2).
HSPB3 plays a critical pro-myogenic role in skeletal muscle development and differentiation (tiago2021smallheatshockprotein pages 1-2, pomella2023heatshockproteins pages 1-2, tiago2021smallheatshockprotein pages 4-6). Functional studies demonstrate that:
These findings establish HSPB3 as not merely a passive component of differentiated muscle but as an active driver of the myogenic program (tiago2021smallheatshockprotein pages 1-2, pomella2023heatshockproteins pages 1-2).
HSPB3 participates in nuclear envelope remodeling during differentiation by regulating the LBR-LMNA tether switch (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6). This process involves:
Through these mechanisms, HSPB3 couples protein quality control to transcriptional reprogramming and chromatin remodeling during muscle cell fate specification (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6).
Unlike HSPB8, which forms a stable complex with the HSP70 co-chaperone BAG3, HSPB3 does not directly participate in the BAG3-dependent protein quality control pathway (morelli2017aninteractionstudy pages 1-2). In mammalian cells, HSPB2 can bind weakly to BAG3 upon overexpression, but HSPB3 actually negatively regulates this HSPB2-BAG3 association (morelli2017aninteractionstudy pages 1-2). In human myoblasts that express HSPB2, HSPB3, HSPB8, and BAG3, the co-chaperone BAG3 interacts selectively with HSPB8 rather than with the HSPB2/HSPB3 complex (morelli2017aninteractionstudy pages 1-2). This finding reinforces HSPB3's functional specialization toward nuclear substrates like LBR rather than the cytoplasmic HSPB8-BAG3-mediated chaperone-assisted selective autophagy (CASA) pathway.
Two missense mutations in HSPB3 have been identified in patients with neuromuscular disease: R7S and R116P (tiago2021smallheatshockprotein pages 1-2, boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3). These mutations link HSPB3 dysfunction to neuromuscular pathology, consistent with its restricted expression pattern and specialized function in muscle and motor neurons.
R7S Mutation: This N-terminal mutation is associated with distal hereditary motor neuropathy type 2C (dHMN2C) and has been discussed in the context of Charcot-Marie-Tooth disease (CMT2) and related peripheral neuropathies (boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3). The precise molecular mechanisms by which R7S causes disease remain less well characterized than those of R116P (boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3).
R116P Mutation: This mutation, located in the conserved α-crystallin domain, has been more extensively studied and causes myopathy characterized by chromatin alterations and muscle fiber disorganization (tiago2021smallheatshockprotein pages 1-2, boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3). The R116P mutant protein exhibits multiple pathogenic features:
The R116P pathogenic mechanism illustrates how HSPB3 mutations can cause disease through both loss of specialized nuclear chaperone function (impaired LBR regulation) and toxic gain-of-function (protein aggregation and UPR activation) (tiago2021smallheatshockprotein pages 1-2, tedesco2022insightsonhuman pages 2-5).
The finding that HSPB3 overexpression can induce differentiation of rhabdomyosarcoma (RMS) cells suggests potential therapeutic applications (tiago2021smallheatshockprotein pages 1-2, pomella2023heatshockproteins pages 1-2). Rhabdomyosarcoma is a highly aggressive pediatric soft tissue sarcoma in which cells exhibit skeletal muscle features but fail to fully differentiate (pomella2023heatshockproteins pages 1-2). Boosting HSPB3 activity might help drive terminal differentiation and reduce malignant proliferation in this context (tiago2021smallheatshockprotein pages 1-2, pomella2023heatshockproteins pages 1-2).
| Feature | HSPB3 summary | Comparison / nuance | Evidence |
|---|---|---|---|
| Verified identity | Human HSPB3 encodes heat shock protein beta-3 (HspB3), a member of the small heat shock protein (sHSP/HSPB) family with a conserved α-crystallin domain (ACD). | Matches UniProt Q12988 annotation and the human sHSP family framework. | (tedesco2022insightsonhuman pages 1-2, boelens2020structuralaspectsof pages 1-2) |
| Molecular size | HSPB3 is a small ~17 kDa protein; reviews list 16.97 kDa and 150 aa. | Smaller than many other HSPBs; classified among tissue-restricted rather than ubiquitous sHSPs. | (tedesco2022insightsonhuman pages 1-2, boelens2020structuralaspectsof pages 1-2) |
| Domain architecture | Contains the canonical ACD flanked by a unique N-terminal region; unlike several other HSPBs, HSPB3 lacks the typical C-terminal architecture associated with stronger oligomerization/chaperone activity. It carries an I/V-X-I/V motif in the N-terminus. | Reviews note that absence of the usual C-terminal motif arrangement helps explain its low oligomerization propensity and distinctive behavior relative to HSPB1/HSPB4/HSPB5. | (tedesco2022insightsonhuman pages 1-2, tiago2021smallheatshockprotein pages 2-4, tedesco2022insightsonhuman pages 2-5) |
| Core biochemical class | HSPB3 is an ATP-independent chaperone/holdase. sHSPs bind non-native proteins to prevent aggregation and can pass clients to ATP-dependent systems such as HSP70/HSP40 for refolding or routing to degradation. | This is the canonical sHSP mechanism; HSPB3 conforms to the family-level ATP-independent holdase model. | (tedesco2022insightsonhuman pages 1-2, boelens2020structuralaspectsof pages 1-2, tedesco2022insightsonhuman pages 2-5) |
| Chaperone potency / specificity | HSPB3 is generally considered to have moderate or selective chaperone activity, rather than the broad promiscuous anti-aggregation activity of HSPB1/HSPB4/HSPB5. | Reviews describe HSPB1/HSPB4/HSPB5 as the most active/promiscuous sHSPs, whereas HSPB2/HSPB3 show intermediate or more selective activity. | (tiago2021smallheatshockprotein pages 2-4, boelens2020structuralaspectsof pages 1-2) |
| Primary experimentally defined substrate | The best-defined HSPB3 client is lamin B receptor (LBR). HSPB3 binds LBR in the nucleoplasm and maintains it in a dynamic state, promoting proper LBR relocalization during differentiation. | This is more specific than the broad anti-aggregation role usually assigned to many sHSPs, making HSPB3 unusually specialized. | (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6) |
| Functional consequence of LBR binding | By regulating LBR mobility/localization, HSPB3 promotes the LBR-to-LMNA chromatin tether switch, enabling transcription of myogenic genes and extracellular-matrix remodeling genes during muscle differentiation. HSPB3 loss increases LBR retention at the nuclear envelope and impairs differentiation. | This places HSPB3 in a nuclear-envelope/chromatin-remodeling arm of myogenesis, not just generic proteostasis. | (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6) |
| Subcellular localization | In differentiating myoblasts, HSPB3 shows heterogeneous localization: cytoplasm + nucleoplasm in some cells, and enrichment at the nuclear envelope (NE) in others. It can form nuclear filaments and colocalizes with lamin B1 at the NE. | Distinct from many sHSPs that are mainly cytoplasmic; HSPB3 has an unusually prominent nuclear/NE pool. | (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 4-6) |
| Nuclear localization determinant | The N-terminal region promotes nuclear accumulation and self-assembly/condensate behavior; once nuclear, the ACD is sufficient to help retain LBR in the nucleoplasm. | Supports a structure-function link between the unique N-terminus and HSPB3’s specialized nuclear role. | (tiago2021smallheatshockprotein pages 4-6) |
| Mitochondrial localization | Unlike many other human sHSPs found in the mitochondrial intermembrane space (IMS), HSPB3 is not imported into mitochondria under the tested conditions. | Adriaenssens et al. specifically note that most sHSPs enter the IMS, but HSPB3 is an exception. | (adriaenssens2023smallheatshock pages 1-2) |
| HSPB2-HSPB3 complex formation | HSPB3 forms a characteristic hetero-oligomeric complex with HSPB2, classically a heterotetramer with a 3:1 HSPB2:HSPB3 ratio; higher assemblies maintaining this stoichiometry have also been reported. | This is one of the best-defined specific pairings among human sHSPs and distinguishes HSPB3 from broadly self-oligomerizing family members. | (morelli2017aninteractionstudy pages 1-2, clark2018terminalregionsconfer pages 1-6) |
| Structural basis of HSPB2-HSPB3 assembly | The HSPB2/HSPB3 heteromer is assembled through the ACDs plus flexible terminal-region “nuts and bolts” involving IXI/V motif-pocket interactions; the full-length structure reveals a plastic heterotetrameric assembly. | Structural plasticity is thought to underlie sHSP cytoprotective function more generally; for HSPB3 it likely contributes to client handling and localization control. | (clark2018terminalregionsconfer pages 1-6) |
| Relationship to BAG3 pathway | In mammalian cells, HSPB2 binds BAG3 weakly, but HSPB3 negatively regulates HSPB2–BAG3 association; in human myoblasts BAG3 preferentially interacts with HSPB8, not HSPB3. | Suggests HSPB3 is not a primary BAG3-associated sHSP, unlike HSPB8, reinforcing functional specialization. | (morelli2017aninteractionstudy pages 1-2) |
| Tissue expression pattern | HSPB3 expression is restricted / tissue-biased, with highest expression in skeletal muscle; it is also reported in cardiac muscle, differentiating myoblasts, motoneurons, fetal brain, and muscle-rich tissues. It is absent from cycling myoblasts and induced upon differentiation. | In contrast, HSPB1/HSPB5/HSPB8 are more widely expressed and stress responsive. | (tiago2021smallheatshockprotein pages 2-4, boelens2020structuralaspectsof pages 1-2, morelli2017aninteractionstudy pages 1-2) |
| Developmental regulation | HSPB3 is developmentally regulated rather than classically heat-shock induced. During myogenesis it is upregulated by MYOD; MYOD occupancy and activating chromatin marks at HSPB3 regulatory regions increase in differentiated muscle cells. | Reviews note HSPB3 does not respond strongly to heat shock, unlike several canonical stress-inducible sHSPs. | (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 1-2, tedesco2022theroleof pages 1-2) |
| Role in myogenesis | HSPB3 is pro-myogenic: depletion blocks differentiation and lowers MYOG expression, whereas overexpression is sufficient to promote differentiation in human myoblasts and even rhabdomyosarcoma cells. | This is one of the clearest functional assignments for HSPB3 in human cells. | (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6) |
| Disease-linked variants | Disease-associated missense variants include R7S and R116P. R116P forms nuclear aggregates, immobilizes LBR, fails to drive myogenic differentiation, and activates the unfolded protein response. | Links HSPB3 dysfunction to neuromuscular disease/myopathy through loss of its specialized nuclear chaperone function rather than only general proteostasis failure. | (tiago2021smallheatshockprotein pages 1-2, boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3) |
| Overall functional interpretation | HSPB3 is best understood as a specialized, muscle-enriched nuclear sHSP chaperone that couples proteostasis-like client handling to nuclear-envelope remodeling and transcriptional reprogramming during muscle differentiation. | This differentiates HSPB3 from broadly stress-protective sHSPs and explains why its disease phenotypes are strongly neuromuscular. | (tiago2021smallheatshockprotein pages 1-2, adriaenssens2023smallheatshock pages 1-2, boelens2020structuralaspectsof pages 1-2, pomella2023heatshockproteins pages 1-2) |
Table: This table summarizes the key molecular, structural, regulatory, localization, and functional properties of human HSPB3, including its specialized interaction with LBR and hetero-oligomerization with HSPB2. It is useful for quickly distinguishing HSPB3 from more canonical, broadly stress-inducible small heat shock proteins.
| HSPB3 mutation | Affected region/domain | Reported clinical phenotype | Key molecular/cellular consequences | Proposed pathogenic mechanism | Functional consequence for HSPB3 | Evidence |
|---|---|---|---|---|---|---|
| R7S | Extreme N-terminal region | Distal hereditary motor neuropathy (dHMN2C); also discussed within broader peripheral neuropathy/CMT-related neuromuscular disease literature | Mechanistic detail is much less developed than for R116P; identified as a disease-associated missense variant in HSPB3 and interpreted within the context of impaired sHSP function in neuromuscular cells (boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3, clark2018terminalregionsconfer pages 1-6) | Likely loss or alteration of specialized HSPB3 chaperone function in muscle/neuronal proteostasis; exact client-specific defect remains unresolved in the cited literature (boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3) | Presumed impairment of normal HSPB3 protective activity in neuromuscular tissues; direct effects on LBR regulation were not clearly established in the cited sources (boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3) | (boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3, clark2018terminalregionsconfer pages 1-6) |
| R116P | α-crystallin domain (ACD); residue 116 lies in the conserved core domain of the sHSP | Myopathy / neuromyopathy with chromatin alterations and muscle fiber disorganization; discussed as a pathogenic HSPB3 mutation in neuromuscular disease reviews (tiago2021smallheatshockprotein pages 1-2, boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3) | Forms intranuclear aggregates, causes LBR immobilization/dysregulation, fails to promote normal myoblast differentiation, and activates the unfolded protein response (UPR) (tiago2021smallheatshockprotein pages 1-2) | Mutant HSPB3 undergoes a toxic conformational/assembly change, producing nuclear aggregation and loss of specialized nuclear chaperone function toward LBR; this disrupts nuclear-envelope/chromatin remodeling needed for myogenesis and induces proteotoxic stress signaling (tiago2021smallheatshockprotein pages 1-2, tedesco2022insightsonhuman pages 2-5) | Unable to induce myoblast differentiation; loses ability to maintain LBR in a dynamic nucleoplasmic state and instead traps it, thereby impairing transcriptional reprogramming during myogenesis (tiago2021smallheatshockprotein pages 1-2) | (tiago2021smallheatshockprotein pages 1-2, boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3, tedesco2022insightsonhuman pages 2-5, clark2018terminalregionsconfer pages 1-6) |
| Overall interpretation of HSPB3 disease variants | N-terminus and ACD are both implicated by known variants | HSPB3 mutations are linked mainly to neuromuscular phenotypes, including motor neuropathy and myopathy | Disease can arise through either poorly defined dysfunction (R7S) or a clearer aggregation/LBR/UPR mechanism (R116P) (tiago2021smallheatshockprotein pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3) | Pathogenesis is consistent with HSPB3 being a muscle-enriched, specialized sHSP, so mutations compromise nuclear proteostasis and/or differentiation-linked chaperone functions rather than only generic heat-shock responses (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 1-2, boelens2020structuralaspectsof pages 1-2) | Mutations reduce HSPB3’s ability to support normal muscle-cell homeostasis and differentiation; for R116P this has been demonstrated directly in cell models (tiago2021smallheatshockprotein pages 1-2) | (tiago2021smallheatshockprotein pages 2-4, tiago2021smallheatshockprotein pages 1-2, boelens2020structuralaspectsof pages 1-2, sarparanta2020neuromusculardiseasesdue pages 1-3, clark2018terminalregionsconfer pages 1-6) |
Table: This table summarizes the currently highlighted disease-associated HSPB3 missense variants, emphasizing their affected regions, clinical phenotypes, and known or proposed pathogenic mechanisms. It is especially useful for distinguishing the relatively well-characterized R116P mechanism from the more limited evidence available for R7S.
Recent research (2021-2024) has significantly advanced our understanding of HSPB3 function beyond its initial characterization as a muscle-specific small heat shock protein. Key conceptual advances include:
Substrate Specificity: Identification of LBR as a primary HSPB3 substrate represents a major advance in understanding sHSP client selection and challenges the view that all sHSPs are broadly promiscuous chaperones (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6).
Nuclear Chaperone Function: Recognition that HSPB3 functions predominantly in the nucleus and at the nuclear envelope, rather than the cytoplasm or mitochondria like most sHSPs, reveals unexpected functional diversification within the sHSP family (tiago2021smallheatshockprotein pages 1-2, adriaenssens2023smallheatshock pages 1-2, tiago2021smallheatshockprotein pages 4-6).
Coupling Proteostasis to Development: The demonstration that HSPB3 links protein quality control to nuclear envelope remodeling and transcriptional reprogramming during myogenesis illustrates how specialized chaperones can serve developmental rather than merely protective functions (tiago2021smallheatshockprotein pages 1-2, tiago2021smallheatshockprotein pages 4-6).
Mechanistic Understanding of Disease: The characterization of R116P pathogenesis provides a molecular framework for understanding how HSPB3 mutations cause neuromuscular disease through disruption of specialized nuclear functions rather than general proteostasis failure (tiago2021smallheatshockprotein pages 1-2, tedesco2022insightsonhuman pages 2-5).
Recent comprehensive reviews emphasize that HSPB3, along with HSPB2, shows intermediate chaperone activity and forms one of the most structurally well-defined heteromeric complexes among human sHSPs (gu2023functionaldiversityof pages 1-3, tedesco2022insightsonhuman pages 1-2, boelens2020structuralaspectsof pages 1-2). The 2023 mitochondrial localization study by Adriaenssens et al. importantly demonstrated that HSPB3 is excluded from the mitochondrial chaperone network that includes most other sHSPs, reinforcing its specialized nuclear role (adriaenssens2023smallheatshock pages 1-2).
HSPB3 represents a highly specialized member of the small heat shock protein family with distinctive structural, regulatory, and functional properties. Unlike the broadly expressed and stress-inducible canonical sHSPs (HSPB1, HSPB4, HSPB5), HSPB3 is:
These features position HSPB3 as a muscle-specific nuclear chaperone that couples proteostasis to developmental transcriptional reprogramming. Disease-associated mutations in HSPB3 cause neuromuscular pathology through disruption of this specialized function, particularly the regulation of nuclear envelope dynamics and chromatin organization during myogenesis. Future research directions include further elucidation of HSPB3's potential additional substrates, detailed structural analysis of the HSPB3-LBR interaction, and exploration of HSPB3 modulation as a therapeutic strategy for neuromuscular diseases and rhabdomyosarcoma.
References
(tedesco2022insightsonhuman pages 1-2): B. Tedesco, R. Cristofani, V. Ferrari, M. Cozzi, P. Rusmini, E. Casarotto, M. Chierichetti, F. Mina, M. Galbiati, M. Piccolella, V. Crippa, and A. Poletti. Insights on human small heat shock proteins and their alterations in diseases. Frontiers in Molecular Biosciences, Feb 2022. URL: https://doi.org/10.3389/fmolb.2022.842149, doi:10.3389/fmolb.2022.842149. This article has 80 citations.
(boelens2020structuralaspectsof pages 1-2): Wilbert C. Boelens. Structural aspects of the human small heat shock proteins related to their functional activities. Cell Stress and Chaperones, 25:581-591, Jul 2020. URL: https://doi.org/10.1007/s12192-020-01093-1, doi:10.1007/s12192-020-01093-1. This article has 53 citations and is from a peer-reviewed journal.
(tiago2021smallheatshockprotein pages 2-4): Tatiana Tiago, Barbara Hummel, Federica F. Morelli, Valentina Basile, Jonathan Vinet, Veronica Galli, Laura Mediani, Francesco Antoniani, Silvia Pomella, Matteo Cassandri, Maria Giovanna Garone, Beatrice Silvestri, Marco Cimino, Giovanna Cenacchi, Roberta Costa, Vincent Mouly, Ina Poser, Esti Yeger-Lotem, Alessandro Rosa, Simon Alberti, Rossella Rota, Anat Ben-Zvi, Ritwick Sawarkar, and Serena Carra. Small heat-shock protein hspb3 promotes myogenesis by regulating the lamin b receptor. Text, May 2021. URL: https://doi.org/10.17863/cam.69495, doi:10.17863/cam.69495. This article has 27 citations and is from a peer-reviewed journal.
(gu2023functionaldiversityof pages 1-3): Chaoguang Gu, Xinyi Fan, and Wei Yu. Functional diversity of mammalian small heat shock proteins: a review. Cells, 12:1947, Jul 2023. URL: https://doi.org/10.3390/cells12151947, doi:10.3390/cells12151947. This article has 49 citations.
(tedesco2022insightsonhuman pages 2-5): B. Tedesco, R. Cristofani, V. Ferrari, M. Cozzi, P. Rusmini, E. Casarotto, M. Chierichetti, F. Mina, M. Galbiati, M. Piccolella, V. Crippa, and A. Poletti. Insights on human small heat shock proteins and their alterations in diseases. Frontiers in Molecular Biosciences, Feb 2022. URL: https://doi.org/10.3389/fmolb.2022.842149, doi:10.3389/fmolb.2022.842149. This article has 80 citations.
(clark2018terminalregionsconfer pages 1-6): Alice R. Clark, Wilma Vree Egberts, Frances D.L. Kondrat, Gillian R. Hilton, Nicholas J. Ray, Ambrose R. Cole, John A. Carver, Justin L.P. Benesch, Nicholas H. Keep, Wilbert C. Boelens, and Christine Slingsby. Terminal regions confer plasticity to the tetrameric assembly of human hspb2 and hspb3. Journal of Molecular Biology, 430:3297-3310, Sep 2018. URL: https://doi.org/10.1016/j.jmb.2018.06.047, doi:10.1016/j.jmb.2018.06.047. This article has 54 citations and is from a domain leading peer-reviewed journal.
(morelli2017aninteractionstudy pages 1-2): Federica F. Morelli, Laura Mediani, Lonneke Heldens, Jessika Bertacchini, Ilaria Bigi, Arianna Dorotea Carrà, Jonathan Vinet, and Serena Carra. An interaction study in mammalian cells demonstrates weak binding of hspb2 to bag3, which is regulated by hspb3 and abrogated by hspb8. Cell Stress and Chaperones, 22:531-540, Jul 2017. URL: https://doi.org/10.1007/s12192-017-0769-x, doi:10.1007/s12192-017-0769-x. This article has 26 citations and is from a peer-reviewed journal.
(tiago2021smallheatshockprotein pages 1-2): Tatiana Tiago, Barbara Hummel, Federica F. Morelli, Valentina Basile, Jonathan Vinet, Veronica Galli, Laura Mediani, Francesco Antoniani, Silvia Pomella, Matteo Cassandri, Maria Giovanna Garone, Beatrice Silvestri, Marco Cimino, Giovanna Cenacchi, Roberta Costa, Vincent Mouly, Ina Poser, Esti Yeger-Lotem, Alessandro Rosa, Simon Alberti, Rossella Rota, Anat Ben-Zvi, Ritwick Sawarkar, and Serena Carra. Small heat-shock protein hspb3 promotes myogenesis by regulating the lamin b receptor. Text, May 2021. URL: https://doi.org/10.17863/cam.69495, doi:10.17863/cam.69495. This article has 27 citations and is from a peer-reviewed journal.
(tiago2021smallheatshockprotein pages 4-6): Tatiana Tiago, Barbara Hummel, Federica F. Morelli, Valentina Basile, Jonathan Vinet, Veronica Galli, Laura Mediani, Francesco Antoniani, Silvia Pomella, Matteo Cassandri, Maria Giovanna Garone, Beatrice Silvestri, Marco Cimino, Giovanna Cenacchi, Roberta Costa, Vincent Mouly, Ina Poser, Esti Yeger-Lotem, Alessandro Rosa, Simon Alberti, Rossella Rota, Anat Ben-Zvi, Ritwick Sawarkar, and Serena Carra. Small heat-shock protein hspb3 promotes myogenesis by regulating the lamin b receptor. Text, May 2021. URL: https://doi.org/10.17863/cam.69495, doi:10.17863/cam.69495. This article has 27 citations and is from a peer-reviewed journal.
(adriaenssens2023smallheatshock pages 1-2): Elias Adriaenssens, Bob Asselbergh, Pablo Rivera-Mejías, Sven Bervoets, Leen Vendredy, Vicky De Winter, Katrien Spaas, Riet de Rycke, Gert van Isterdael, Francis Impens, Thomas Langer, and Vincent Timmerman. Small heat shock proteins operate as molecular chaperones in the mitochondrial intermembrane space. Nature Cell Biology, 25:467-480, Jan 2023. URL: https://doi.org/10.1038/s41556-022-01074-9, doi:10.1038/s41556-022-01074-9. This article has 90 citations and is from a highest quality peer-reviewed journal.
(tedesco2022theroleof pages 1-2): Barbara Tedesco, Veronica Ferrari, Marta Cozzi, Marta Chierichetti, Elena Casarotto, Paola Pramaggiore, Francesco Mina, Mariarita Galbiati, Paola Rusmini, Valeria Crippa, Riccardo Cristofani, and Angelo Poletti. The role of small heat shock proteins in protein misfolding associated motoneuron diseases. International Journal of Molecular Sciences, 23:11759, Oct 2022. URL: https://doi.org/10.3390/ijms231911759, doi:10.3390/ijms231911759. This article has 21 citations.
(pomella2023heatshockproteins pages 1-2): Silvia Pomella, Matteo Cassandri, Francesco Antoniani, Samuele Crotti, Laura Mediani, Beatrice Silvestri, Margherita Medici, Rossella Rota, Alessandro Rosa, and Serena Carra. Heat shock proteins: important helpers for the development, maintenance and regeneration of skeletal muscles. Muscles, 2:187-203, Apr 2023. URL: https://doi.org/10.3390/muscles2020014, doi:10.3390/muscles2020014. This article has 22 citations.
(sarparanta2020neuromusculardiseasesdue pages 1-3): J. Sarparanta, P. Jonson, S. Kawan, and B. Udd. Neuromuscular diseases due to chaperone mutations: a review and some new results. International Journal of Molecular Sciences, Feb 2020. URL: https://doi.org/10.3390/ijms21041409, doi:10.3390/ijms21041409. This article has 91 citations.